Daniel D. Burgess

Chief Financial Officer, HARBOR DIVERSIFIED, INC.

Companies

Cidara TherapeuticsBoard member Apr 14, 2015 to now¹
Arbutus BiopharmaBoard member Mar 27, 2017 to May 24, 2024²
Nabriva Therapeutics plcBoard member Dec 30, 2016 to Aug 4, 2022³
HARBOR DIVERSIFIED, INC.Chief financial officer Feb 15, 2006 to Feb 15, 2007⁴
HARBOR DIVERSIFIED, INC.Chief operating officer Feb 15, 2006 to Feb 15, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cidara Therapeutics CDTX0 shares⁵Jan 7, 2026
Nabriva Therapeutics plc10,384 shares⁶Aug 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 7, 2026Returned to company 150 shares at $221.50 of Cidara Therapeutics⁵
Aug 2, 2022Sold 11,341 shares at $0.19 of Nabriva Therapeutics plc⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCidara Therapeutics, Board member
2
SEC EDGARArbutus Biopharma, Board member
3
SEC EDGARNabriva Therapeutics plc, Board member
4
SEC EDGARHARBOR DIVERSIFIED, INC., Chief financial officer
5
SEC EDGARCidara Therapeutics shares after the filing of Jan 7, 2026
6
SEC EDGARNabriva Therapeutics plc shares after the filing of Aug 2, 2022